Browsing Tag
CRDMO
5 posts
Frontage Laboratories adds oncology and radiolabeled capacity to Secaucus Phase I unit for integrated CRDMO execution
Frontage Laboratories expands early-phase clinical research in U.S. and China. Find out how its oncology and AME focus could reshape sponsor strategies.
Anthem Biosciences (NSE: ANTHEM) Q2 FY26 results: Can strong CRDMO tailwinds keep driving profitability?
Anthem Biosciences Q2 FY26 results reveal strong CRDMO-led growth and 44.5% EBITDA margins. Find out what’s driving investor sentiment and what’s next.
Sai Life Sciences (NSE: SAILIFE) Q2 FY26 profit doubles on CRDMO demand, high-value tech expansion
Sai Life Sciences profit doubled in Q2 FY26, driven by peptide, ADC, and oligo expansion. See how the CRDMO firm is gaining margin and investor traction.
WuXi Biologics wins EMA approval in Ireland as WuXiUP automation signals new chapter in global biologics manufacturing
WuXi Biologics secures EMA approval in Ireland and achieves WuXiUP automated continuous production, reinforcing global dual sourcing and biomanufacturing innovation.
Can Atombeat and BioDuro’s trillion-compound AI engine transform peptide drug discovery in 2025?
Find out how Atombeat and BioDuro are using AI to revolutionize peptide drug discovery with faster timelines and lower R&D costs.